EXPO Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

67.030

Open

66.110

VWAP

66.38

Vol

432.93K

Mkt Cap

3.25B

Low

65.225

Amount

28.74M

EV/EBITDA(TTM)

23.33

Total Shares

48.61M

EV

3.03B

EV/OCF(TTM)

23.00

P/S(TTM)

6.38

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.

Show More

Events Timeline

(ET)

2026-04-30

17:10:00

Exponent's Board Increases Share Repurchase Authority by $50M

2026-04-30

16:21:00

Q1 Revenue Reaches $166.3M, Exceeds Consensus

2026-04-30

16:20:00

Sees Q2 EBITDA to be 27.0%-27.8% of Revenues

2026-04-30

16:20:00

Sees FY26 EBITDA at 27.6%-28.1% of Revenues

2026-04-06 (ET)

2026-04-06

16:40:00

Exponent Appoints Eric Anderson as CFO

2026-02-05 (ET)

2026-02-05

16:20:00

Sees Q1 EBITDA at 27.5%-28.5% of Revenues

2026-02-05

16:20:00

Exponent Raises Quarterly Cash Dividend to 31 Cents per Share

News

seekingalpha

09:11 AMseekingalpha

Exponent Reports Strong Q1 2026 Growth Driven by AI Demand

seekingalpha

04-30seekingalpha

Exponent Reports Q1 2026 Earnings with Positive Outlook

Yahoo Finance

04-30Yahoo Finance

Exponent Inc. Reports Q1 Earnings of $29.6 Million

Fool

Exponent CEO Sells Shares to Enhance Liquidity

seekingalpha

04-06seekingalpha

Exponent Appoints New Executives and Board Changes

Newsfilter

04-06Newsfilter

Exponent Appoints New Executives to Drive Growth

3 Analyst Rating

Wall Street analysts forecast EXPO stock price to rise

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

81.00

Averages

85.50

High

90.00

Current: 0.000

Low

81.00

Averages

85.50

High

90.00

UBS

Joshua Chan

Neutral

downgrade

$85 -> $75

AI Analysis

2026-05-01

New

Reason

UBS

Joshua Chan

Price Target

$85 -> $75

AI Analysis

2026-05-01

New

downgrade

Neutral

Reason

UBS analyst Joshua Chan lowered the firm's price target on Exponent to $75 from $85 and keeps a Neutral rating on the shares. The company posted a "solid" quarter with few changes on the 2026 outlook, the analyst tells investors in a research note.

JPMorgan

NULL -> Overweight

maintain

$100 -> $95

2026-03-26

Reason

JPMorgan

Price Target

$100 -> $95

2026-03-26

maintain

NULL -> Overweight

Reason

JPMorgan lowered the firm's price target on Exponent to $95 from $100 and keeps an Overweight rating on the shares. The firm updated models in the North American small-cap industrials sector. The group is "undergoing a strategic rebalance, driven by evolving market dynamics and sector-specific growth opportunities," the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for EXPO

Unlock Now

Valuation Metrics

The current forward P/E ratio for Exponent Inc (EXPO.O) is 29.33, compared to its 5-year average forward P/E of 45.30. For a more detailed relative valuation and DCF analysis to assess Exponent Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

45.30

Current PE

29.33

Overvalued PE

54.36

Undervalued PE

36.25

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

31.78

Current EV/EBITDA

19.85

Overvalued EV/EBITDA

38.59

Undervalued EV/EBITDA

24.98

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

9.21

Current PS

5.00

Overvalued PS

11.35

Undervalued PS

7.08

Financials

AI Analysis

Annual

Quarterly

Whales Holding EXPO

Royce & Associates, LP

Granite Investment Partners, LLC

Nationwide Fund Advisors

Roffman Milller Associates Inc

Conestoga Capital Advisors, LLC

Kayne Anderson Rudnick Investment Management, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Exponent Inc (EXPO) stock price today?

The current price of EXPO is 66.89 USD — it has increased 1.07

What is Exponent Inc (EXPO)'s business?

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.

What is the price predicton of EXPO Stock?

Wall Street analysts forecast EXPO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXPO is85.50 USD with a low forecast of 81.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Exponent Inc (EXPO)'s revenue for the last quarter?

Exponent Inc revenue for the last quarter amounts to 129.38M USD, increased 4.54

What is Exponent Inc (EXPO)'s earnings per share (EPS) for the last quarter?

Exponent Inc. EPS for the last quarter amounts to 0.49 USD, increased 6.52

How many employees does Exponent Inc (EXPO). have?

Exponent Inc (EXPO) has 1212 emplpoyees as of May 01 2026.

What is Exponent Inc (EXPO) market cap?

Today EXPO has the market capitalization of 3.25B USD.